Day One Biopharmaceuticals, Inc. Share Price
DAWNDay One Biopharmaceuticals, Inc. Stock Performance
Open $10.82 | Prev. Close $10.50 | Circuit Range N/A |
Day Range $10.35 - $10.98 | Year Range $5.63 - $13.19 | Volume 1,47,801 |
Average Traded $10.55 |
Day One Biopharmaceuticals, Inc. Share Price Chart
About Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Day One Biopharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Feb-26 | $10.82 | $10.49 | +0.00% |
05-Feb-26 | $10.82 | $10.49 | -6.09% |
03-Feb-26 | $11.82 | $11.17 | -3.04% |
02-Feb-26 | $11.23 | $11.52 | +3.18% |
30-Jan-26 | $11.20 | $11.16 | +0.22% |
29-Jan-26 | $11.77 | $11.14 | -5.43% |
28-Jan-26 | $12.49 | $11.78 | -4.54% |